Related coverage linked through entity extraction aliases.
May 15, 2026
Researchers identified the first comprehensive group of human monoclonal antibodies targeting measles virus. The study found antibodies against both H and F proteins, including 4F09, which reduced virus to undetectable levels in an animal model.
Mar 19, 2026
Altesa BioSciences closed an oversubscribed $75 million Series B financing led by Forbion with participation from Sanofi to advance vapendavir, a first-in-class oral antiviral targeting rhinovirus infections in COPD patients.
Feb 12, 2026
The mRNA therapy market is forecast to grow from USD 13.6 billion in 2025 to USD 70.0 billion by 2035 at a 17.8% CAGR, driven by expanding applications beyond vaccines into oncology, rare diseases, and infectious disease treatments including genital herpes.
